DEVELOPMENT OF LLE AND SPE PROCEDURES AND ITS APPLICATIONS FOR DETERMINATION OF OLMESARTAN IN HUMAN PLASMA USING RP-HPLC AND HPTLC

REFERENCES

• Nussberger , J. ; Koike , H. Antagonizing the angiotensin II subtype i receptor: a focus on Olmesartan Medoxomil . Clin. Therapeut . 2004 , 26 A , 12 – 20 .
   Web of Science ®Google Scholar
• Mire , D.E. ; Silfani , T.N. ; Pugsley , M.K. A review of the structural and functional features of Olmesartan Medoxomil, an angiotensin receptor blocker. J. Cardiovasc. Pharmacol. 2005, 46 (5), 585–93.
   PubMed Web of Science ®Google Scholar
• Gardner , S.F. ; Franks , A.M. Olmesartan Medoxomil: the seventh angiotensin receptor antagonist . Ann, Pharmacother. 2003 , 37 ( 1 ), 99 – 105 .
   PubMed Web of Science ®Google Scholar
• Kereiakes , D.J. ; Neutel , J.M. ; Punzi , H.A. ; Xu , J. ; Lipka , L.J. ; Dubiel , R. Efficacy and safety of Olmesartan Medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate . Am. J. Cardiovasc. Drugs 2007 , 7 ( 5 ), 361 – 72 .
   PubMed Web of Science ®Google Scholar
• Celebier , M. ; Altinoz , S. Development of a CZE method for the determination of Olmesartan Medoxomil in tablets . Chromatographia. 2007 , 66 , 929 – 933 .
   Web of Science ®Google Scholar
• Sagirli , O. ; Onal , A. ; Toker , S.E. ; Sensoy , D. Simultaneous HPLC analysis of Olmesartan and hydrochlorothiazide in combined tablets and in vitro dissolution studies . Chromatographia 2007 , 66 , 213 – 218 .
   Web of Science ®Google Scholar
• Shah , N.J. ; Suhagia , B.N. ; Shah , R.R. ; Patel , N.M. Development and validation of a simultaneous HPTLC method for the estimation of Olmesartan Medoxomil and hydrochlorothiazide in tablet dosage form 2007 , 69 ( 6 ), 834 – 836 .
   Google Scholar
• Murakami , T.H. ; Konno , N. ; Fukutsu , M. ; Onodera , T. ; Kawasaki , F.K. Identification of a degradation product in stressed tablets of Olmesartan Medoxomil by the complementary use of HPLC hyphenated techniques . J. Pharm. Biomed. Anal. 2008 , 47 , 553 – 559 .
   PubMed Web of Science ®Google Scholar
• Trivedi , P. ; Kartikeyan , C. ; Kachave , R. ; Bhadane , R.N. Stability indicating assay method for estimation of Olmesartan Medoxomil and its metabolite . J. Liq. Chromatogr. & Rel. Technol. 2009 , 32 , 1516 – 1526 .
   Web of Science ®Google Scholar
• Liu , D.P. ; Hu , N. ; Matsushima , X. ; Li , L. ; Li , J.J. Quantitative determination of Olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry . J. Chromatogr. B 2007 , 856 , 190 – 197 .
   PubMed Web of Science ®Google Scholar
• Vaidya , V.V. ; Roy , S.M.N. ; Yetal , S.M. ; Joshi , S.S. ; Parekh , S.A. LC-MS-MS determination of Olmesartan in human plasma . Chromatographia 2008 , 67 , 147 – 150 .
   Web of Science ®Google Scholar
• US Department of Health and Human Services Food and Drug Administration, Guidance for Industry: bioanalytical Method validation ., US Department of Health and Human Services : Rockville , MD , 2001
   Google Scholar
• Bansal , S. ; DeStefano , A. Key elements of bioanalytical method validation for small molecules . AAPS J. 2007 , 9 ( 1 ), E109 – E114 .
   PubMed Web of Science ®Google Scholar
• Jiang , L. ; He , L. ; Fountoulakis , M. Comparison of protein precipitation methods for sample preparation prior to proteomic analysis . J. Chromatogr. A 2004 , 1023 , 317 – 320 .
   PubMed Web of Science ®Google Scholar
• Almeida , A.M. ; Castel-Branco , M.M. ; Falcao , A.C. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods . J. Chromatogr. B 2002 , 774 , 215 – 222 .
   PubMed Web of Science ®Google Scholar